IsoRay, Inc. Receives No List of Observations (Form FDA 483) in FDA Inspection

RICHLAND, Wash.--(BUSINESS WIRE)--IsoRay, Inc. (AMEX:ISR) announced today the completion of a baseline inspection by the Food and Drug Administration (FDA) for all its Quality Systems.